Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00528970 · ClinicalTrials.gov registry record · Phase 3

A Study Evaluating Intravenous (IV) MOA-728 for the Treatment of Postoperative Ileus (POI) in Participants After Ventral Hernia Repair

A Phase 3 study of Ileus, sponsored by Bausch Health Americas.

Completed
Registry status
Phase 3
Development phase
374
Enrollment target
20
Study locations

NCT00528970 is a Phase 3 study of Ileus that has completed, run by Bausch Health Americas. The registered enrollment target is 374 participants, roughly in line with the 410-participant average among 5 other Ileus trials with a reported enrollment target. The trial reports 20 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00528970, a Phase 3 study of Ileus, has completed, sponsored by Bausch Health Americas.

COMPLETED
Registry status
Phase 3
Development phase
374 participants
Enrollment target
20
Study locations

Study Summary

This study will evaluate the safety and efficacy of two different dose regimens (12 milligrams \[mg\] and 24 mg) of IV MOA-728 versus placebo in shortening the time to return of bowel function in participants receiving opioid analgesia administered via patient-controlled anesthesia (PCA), and who had undergone repair of large (greater than or equal to \[≥\]10 centimeters) ventral hernias with or without a mesh prosthesis via laparotomy or laparoscopy.

Conditions Studied

Ileus

Interventions

  • DRUG Placebo
  • DRUG MOA-728

Study Locations (20)

Florida

  • - Inverness
  • - Jacksonville
  • - Jacksonville
  • - Melbourne
  • - Miami
  • - Miami
  • - Naples
  • - Orlando
  • - Pensacola

California

  • - Colton
  • - Laguna Hills
  • - Loma Linda
  • - Long Beach
  • - Los Angeles
  • - Orange
  • - San Jose
  • - Santa Barbara

Colorado

  • - Denver
  • - Denver

Arkansas

  • - Benton

Trial Details

FieldValue
Enrollment Target 374 participants
Start Date 2007-10-17
Est. Completion 2008-02-05
Phase Phase 3

Sponsor

Bausch Health Americas

168 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00528970

The ClinicalTrials.gov registry entry for NCT00528970 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 374 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 410-participant average among 5 other Ileus trials with a reported enrollment target. The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ileus appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00528970 reports 20 study locations spanning 4 distinct geographic areas - top geographies include Florida, California, Colorado.

Frequently Asked Questions

What is clinical trial NCT00528970 about?

NCT00528970 is a clinical study titled "A Study Evaluating Intravenous (IV) MOA-728 for the Treatment of Postoperative Ileus (POI) in Participants After Ventral Hernia Repair". This study will evaluate the safety and efficacy of two different dose regimens (12 milligrams \[mg\] and 24 mg) of IV MOA-728 versus placebo in shortening the time to return of bowel function in participants receiving opioid analgesia administered via patient-controlled anesthesia (PCA), and who ha...

What is the current status of trial NCT00528970?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 374 participants. The study started on 2007-10-17. Estimated completion is 2008-02-05.

What conditions does trial NCT00528970 study?

This clinical trial studies the following conditions: Ileus.

What interventions are being tested in trial NCT00528970?

The interventions under investigation include: Placebo (DRUG), MOA-728 (DRUG).

Who is sponsoring clinical trial NCT00528970?

This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00528970 being conducted?

This trial has 20 study locations across Arkansas, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Ileus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Ileus

All registered trials for this condition

Arkansas

All trials with a study site in Arkansas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.